Clopidogrel

CAS 113665-84-2 3 current records 4 historicalSmall Molecule

Who holds supplier records for Clopidogrel? 3 organisations hold a current record for Clopidogrel: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (2) and France (1).

Most records are filed under another form of this substance: Clopidogrel Bisulfate (40 current sources), Clopidogrel Besilate (6 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Clopidogrel: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/clopidogrel

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    2 of the 3 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Clopidogrel. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Dr. Reddy's Laboratories Ltd.
    Active DMF 22568, 35506 · latest filing Dec 2020
    India Company GMP cert on record
  • MSN LIFE SCIENCES PRIVATE LIMITED
    Active DMF 34240 · latest filing Oct 2019
    India Company GMP cert on record
  • Sanofi Winthrop Industrie
    Active DMF 14809 · latest filing Mar 2000
    France Company GMP cert on record
Need Clopidogrel sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (4)

Organisations whose Type II DMFs for Clopidogrel are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • ALP PHARM BEIJING CO LTD
    Inactive DMF 27589 · filed Sept 2013
  • India · Inactive DMF 20923 · filed Dec 2007
  • BASF ORGAMOL PHARMA SOLUTIONS SA
    Inactive DMF 15458 · filed May 2001
  • CHINOIN PHARMACEUTCIAL AND CHEMICAL WORKS CO LTD
    Inactive DMF 14849 · filed May 2000

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Clopidogrel is an antiplatelet medication used to reduce the risk of heart disease and stroke in those at high risk. It works by inhibiting platelet aggregation, thereby preventing clot formation.

Chemical identity

IUPAC name
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
Canonical SMILES
COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
InChIKey
GKTWGGQPFAXNFI-HNNXBMFYSA-N
Synonyms
(+)-(s)-clopidogrel, nsc-758613, r 130964, r-130964, sr 25990, sr-25990, thrombo, zyllt

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
P2Y12 Platelet Inhibitor
Mechanism of action
Cytochrome P450 2C8 Inhibitors; P2Y12 Receptor Antagonists
Physiologic effect
Decreased Platelet Aggregation

Therapeutic areas

CardiovascularHematologyThrombosis

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Clopidogrel?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Clopidogrel: Dr. Reddy's Laboratories Ltd. (India), MSN LIFE SCIENCES PRIVATE LIMITED (India) and Sanofi Winthrop Industrie (France). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Clopidogrel Drug Master Files are active?

Dr. Reddy's Laboratories Ltd. (DMF 22568, 35506), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 34240) and Sanofi Winthrop Industrie (DMF 14809). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Clopidogrel records mean?

4 organisations have only inactive Type II DMFs for Clopidogrel. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Clopidogrel supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Clopidogrel?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.